Table 3.
Univariable analysis of the risk factors for gallbladder polyps
|
Variables
|
OR
|
95%CI
|
P
value
|
| BMI (kg/m2) | |||
| < 23 | 1.000 | ||
| ≥ 23, < 25 | 1.050 | 0.893-1.235 | 0.552 |
| ≥ 25 | 0.935 | 0.806-1.085 | 0.378 |
| Waist circumference (cm) | |||
| ≤ 90 (male), ≤ 80 (female) | 1.000 | ||
| > 90 (male), > 80 (female) | 1.057 | 0.925-1.208 | 0.413 |
| Hypertension | |||
| No | 1.000 | ||
| Yes | 1.019 | 0.896-1.159 | 0.776 |
| Diabetes | |||
| No | 1.000 | ||
| Yes | 0.861 | 0.685-1.081 | 0.197 |
| Metabolic syndrome | |||
| No | 1.000 | ||
| Yes | 0.975 | 0.836-1.139 | 0.753 |
| AST (IU/L) | 0.991 | 0.986-0.996 | 0.001 |
| ALT (IU/L) | 0.994 | 0.991-0.998 | 0.001 |
| Alkaline phosphatase (IU/L) | 0.997 | 0.994-1.001 | 0.100 |
| Gamma-glutamyltransferase (IU/L) | 0.999 | 0.997-1.000 | 0.090 |
| hs-CRP (mg/dL) | 1.076 | 0.944-1.226 | 0.273 |
| CEA (ng/mL) | 1.018 | 0.956-1.085 | 0.574 |
| CA19-9 (IU/mL) | 0.998 | 0.992-1.004 | 0.549 |
| HBsAg | |||
| No | 1.000 | ||
| Yes | 1.255 | 0.885-1.779 | 0.203 |
| HCV Ab | |||
| No | 1.000 | ||
| Yes | 0.835 | 0.294-2.375 | 0.736 |
| Total cholesterol (mg/dL) | |||
| < 200 | 1.000 | ||
| 200-240 | 0.948 | 0.824-1.091 | 0.459 |
| ≥ 240 | 0.875 | 0.708-1.080 | 0.213 |
| Triglyceride (mg/dL) | |||
| < 150 | 1.000 | ||
| ≥ 150 | 0.932 | 0.798-1.088 | 0.372 |
| HDL cholesterol (mg/dL) | |||
| > 40 (male), > 50 (female) | 1.000 | ||
| ≤ 40 (male), ≤ 50 (female) | 1.041 | 0.887-1.223 | 0.621 |
| Sarcopenia | |||
| No | 1.000 | ||
| Yes | 0.797 | 0.616-1.031 | 0.084 |
| Visceral fat area (cm2) | |||
| Quartile I (male < 81.8, female < 55.2) | 1.000 | ||
| Quartile II (male 81.8-100.8, female 55.2-71.6) | 1.069 | 0.890-1.283 | 0.477 |
| Quartile III (male 100.8-121.8, female 71.6-92.5) | 0.951 | 0.793-1.140 | 0.585 |
| Quartile IV (male > 121.8, female > 92.5) | 0.853 | 0.721-1.010 | 0.066 |
| Fatty liver | |||
| No | 1.000 | ||
| Yes | 1.178 | 1.035-1.340 | 0.013 |
OR: Odds ratio; CI: Confidence level; BMI: Body mass index; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; hs-CRP: High-sensitivity C-reactive protein; CEA: Carcinoembryonic antigen; CA19-9: Carbohydrate antigen 19-9; HBsAg: Hepatitis B virus surface antigen; HCV Ab: Hepatitis C virus antibody; HDL: High-density lipoprotein.